OptimizeRx Corp
OPRX- Exchange
- Nasdaq
- Industry
- Services-Business Services, NEC
- SEC CIK
- 0001448431
No open-market purchases or sales by OptimizeRx Corp insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $64.2M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding OptimizeRx Corp changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 180 | 153 | −27 |
| Shares | 15.0M | 15.5M | +521.8K (+3.5%) |
| Value | $930.5M | $585.1M | −$345.4M (−37.1%) |
New holders (20)
Institutions that held OptimizeRx Corp at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Summit Creek Advisors LLC | 217,193 | $8.19M | 0.93% |
| Group One Trading, L.P. | 89,933 | $3.39M | 0.07% |
| Premier Fund Managers Ltd | 60,904 | $2.32M | 0.08% |
| Citadel Advisors LLC | 52,488 | $1.98M | 0.00% |
| Royce & Associates LP | 44,000 | $1.66M | 0.01% |
| Vontobel Holding Ltd. | 40,025 | $1.52M | 0.01% |
| Quadrature Capital Ltd | 19,245 | $726.0K | 0.03% |
| Amalgamated Financial Corp. | 8,569 | $323.0K | 0.00% |
| Susquehanna International Group, LLP | 8,135 | $307.0K | 0.00% |
| Mesirow Financial Investment Management, Inc. | 8,027 | $303.0K | 1.02% |
| Balyasny Asset Management LLC | 7,700 | $290.0K | 0.00% |
| Stifel Financial Corp | 7,375 | $278.0K | 0.00% |
| Graham Capital Management, L.P. | 6,867 | $258.0K | 0.01% |
| Rockefeller Capital Management L.P. | 3,500 | $131.0K | 0.00% |
| Point72 Hong Kong Ltd | 1,372 | $52.0K | 0.00% |
| Compagnie Lombard Odier SCmA | 410 | $15.0K | 0.00% |
| Fifth Third Bancorp | 55 | $2.00K | 0.00% |
| Dark Forest Capital Management LP | 62 | $2.00K | 0.00% |
| IFP Advisors, Inc | 21 | $1.00K | 0.00% |
| Glassman Wealth Services | 4 | $0 | 0.00% |
Sold out (47)
Institutions that held OptimizeRx Corp at the end of Q4 2021 and filed for Q1 2022 without it.